CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-4/A Deal Registration Statement - Business Combination
- 8-K Event Material agreement
- 425 Deal Prospectus/Communication re Business Combination
- 4 Shares withheld for taxes CEO gave up 170 shares (to pay taxes)
- 4 Shares withheld for taxes SVP of Finance gave up 98 shares (to pay taxes)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Auditor change
- UPLOAD Other SEC-generated Letter
- 4 Shares withheld for taxes SVP of Finance gave up 1,178 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 2,453 shares (to pay taxes)
- S-4 Deal Registration Statement - Business Combination
- 4 Shares withheld for taxes SVP of Finance gave up 97 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 170 shares (to pay taxes)
- 8-K Event Material agreement · New debt or obligation · Executive or director change · Regulation FD disclosure
- 425 Deal Prospectus/Communication re Business Combination
- 4 Shares withheld for taxes CEO gave up 170 shares (to pay taxes)
- 4 Shares withheld for taxes SVP of Finance gave up 98 shares (to pay taxes)
- SC 13D/A Stake Beneficial Ownership Report
Page 23 of 77 · 1,525 filings